BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16200487)

  • 1. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood.
    Emmel M; Sreeram N; deGiovanni JV; Brockmeier K
    Z Kardiol; 2005 Oct; 94(10):699-703. PubMed ID: 16200487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in children.
    Emmel M; Sreeram N
    Neth Heart J; 2005 Dec; 13(12):448-451. PubMed ID: 25696442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
    Riedlbauchová L; Janoušek J; Veselka J
    J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
    Crossen K; Jones M; Erikson C
    Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
    Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
    Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
    Fitzgerald P; Kusumoto F
    J Interv Card Electrophysiol; 2018 Aug; 52(3):403-408. PubMed ID: 30097789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous trans-apex intra-septal radiofrequency ablation of hypertrophic cardiomyopathy.
    Zuo L; Sun C; Yang J; Liu B; Zhou M; Guo R; Yu S; Ge J; Xiong L; Liu L
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):97-100. PubMed ID: 28949276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency septal reduction for hypertrophic obstructive cardiomyopathy in children.
    Sreeram N; Emmel M; de Giovanni JV
    J Am Coll Cardiol; 2011 Dec; 58(24):2501-10. PubMed ID: 22133850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
    Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
    Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.
    Valdigem BP; Correia EB; Moreira DAR; Bihan DL; Pinto IMF; Abizaid AAC; Andalaft RB; Paladino Filho AT; Silva HAGPD; Viesi JHZ
    Arq Bras Cardiol; 2022 May; 118(5):861-872. PubMed ID: 35137775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
    Brown ML; Schaff HV
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.